Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer.
Jul 2009 - Int. J. Oncol.; 35(3):1019-6439 [PMID:19639177]
[Lemoine FM] [Cherai M] [Giverne C] [Dimitri D] [Rosenzwajg M] [Trebeden-Negre H] [Chaput N] [Barrou B] [Thioun N] [Gattegnio B] [Selles F] [Six A] [Azar N] [Lotz JP] [Buzyn A] [Sibony M] [Delcourt A] [Boyer O] [Herson S] [Klatzmann D] [Lacave R]

Characteristics of hybrid cells obtained by dendritic cell/tumour cell fusion in a T-47D breast cancer cell line model indicate their potential as anti-tumour vaccines.
Nov 2007 - Int. J. Oncol.; 31(6):1019-6439 [PMID:17982663]
[Serhal K] [Baillou C] [Ghinea N] [Fontanges P] [Dupuy FP] [Lemoine FM] [Lacave R]